Under construction – not a live service
Sign in
Active, not recruitingNo phase

Persona Partial Knee Clinical Outcomes Study

Key facts

Who runs it
Zimmer Biomet
Where
Albuquerque, Beverly, Chicago, Columbia, Fremont, Golden, Mount Vernon, New Castle, and Troy, United StatesSee the 9 sitesAlso in 9 other countries, 15 sites
Trial code
Status
Active, not recruiting
People taking part
757 people enrolled
Started
8 Feb 2017
Expected to end
Sept 2030
Type of study
Interventional
Treatments tested
  • Persona Partial Knee system
Record updated
22 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 23 criteriaShow less

Who can take part

  • Patient is at least 18 years of age
  • Patient qualifies for knee arthroplasty based upon physical exam and medical history, and meets the approved indications for use of the Persona Partial Knee system
  • Patient has participated in a study-related Informed Consent process
  • Patient is willing and able to provide written Informed Consent by signing and dating the IRB/EC approved Informed Consent form
  • Patient is willing and able to complete scheduled study procedures and follow-up evaluations
  • Independent of study participation, patient is a candidate for the commercially available Persona Partial Knee, implanted in accordance with product labeling

Who cannot take part

  • Patient is currently participating in any other surgical intervention studies or pain management studies
  • Infection, sepsis, and osteomyelitis
  • Rheumatoid arthritis or other forms of inflammatory joint disease
  • Insufficiency of the collateral, anterior or posterior cruciate ligaments which would preclude stability of the device
  • Uncooperative patient or patient with neurologic disorders who is incapable of following directions
  • Metabolic disorders which may impair bone formation
  • Distant foci of infections which may spread to the implant site
  • Vascular insufficiency, muscular atrophy, neuromuscular disease
  • Charcot's disease
  • Full thickness damage to the weight bearing area of the contralateral compartment
  • Insufficient bone stock to provide adequate support and/or fixation to the prosthesis
  • Osteomalacia
  • Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
  • Incomplete or deficient soft tissue surrounding the knee
  • Fixed varus deformity (not passively correctable) of greater than 15 degrees
  • Fixed flexion deformity (not passively correctable) of greater than 15 degrees
  • Patient is pregnant or considered a member of a protected population (e.g., prisoner, mentally incompetent, etc.)

Where in United States

Also in 9 other countries, 15 sites

  • New Mexico OrthopaedicsAlbuquerque, United StatesNo longer taking part
  • Sports Medicine NorthBeverly, United StatesNo longer taking part
  • Midwest Orthopaedics at RushChicago, United StatesNo longer taking part
  • Midlands Orthopaedics & NeurosurgeryColumbia, United StatesNo longer taking part
  • Sah Orthopaedic AssociatesFremont, United StatesNo longer taking part
  • Panorama Orthopedics & Spine CenterGolden, United StatesNo longer taking part
  • Skagit Regional Clinics-RiverbendMount Vernon, United StatesNo longer taking part
  • Henry County Orthopedics and Sports MedicineNew Castle, United StatesNo longer taking part
  • Troy Orthopaedic AssociatesTroy, United StatesNo longer taking part

About the trial

What the trial wants to find out

The primary objective of this study is to obtain implant survivorship and clinical outcomes data for the commercially available Persona Partial Knee System.

The group in the trial

  • PPK subjectsOther group

    Subjects that receive the Persona Partial Knee system

    Treatment: Persona Partial Knee system

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
22 April 2026